George B. Kehner, Ph.D. - Related publications

Affiliations: 
2002 Temple University, Philadelphia, PA, United States 
Area:
Pharmacology, Neuroscience Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
18 most relevant papers in past 60 days:
Year Citation  Score
2022 Akins N, Mishra N, Harris H, Dudhipala N, Kim SJ, Keasling A, Majumdar S, Zjawiony J, Paris J, Ashpole N, Le H. 6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects. Chemmedchem. PMID 35043597 DOI: 10.1002/cmdc.202100684   
2022 Sharp JL, Pearson T, Smith MA. Sex differences in opioid receptor mediated effects: Role of androgens. Neuroscience and Biobehavioral Reviews. 134: 104522. PMID 34995646 DOI: 10.1016/j.neubiorev.2022.104522   
2022 Wang C, Sun S, Jiao J, Yu X, Huang S. Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats. Bmc Anesthesiology. 22: 19. PMID 35021986 DOI: 10.1186/s12871-022-01568-x   
2022 Szczepańska K, Podlewska S, Dichiara M, Gentile D, Patamia V, Rosier N, Mönnich D, Ruiz Cantero MC, Karcz T, Łażewska D, Siwek A, Pockes S, Cobos EJ, Marrazzo A, Stark H, et al. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties. Acs Chemical Neuroscience. 13: 1-15. PMID 34908391 DOI: 10.1021/acschemneuro.1c00435   
2022 Qin J, Cai Y, Xu Z, Ming Q, Ji SY, Wu C, Zhang H, Mao C, Shen DD, Hirata K, Ma Y, Yan W, Zhang Y, Shao Z. Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nature Communications. 13: 300. PMID 35027551 DOI: 10.1038/s41467-022-27975-9   
2022 Finlay DB, Nguyen T, Gamage TF, Chen S, Barrus DG, Patel PR, Thomas BF, Wiley JL, Zhang Y, Glass M. Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018. Pharmacology Research & Perspectives. 10: e00901. PMID 35041297 DOI: 10.1002/prp2.901   
2022 Hou Z, Jin Y, Li Y, Fan H, Xiao C, Li Q, Zhang Y. Immobilization of peroxisome proliferator-activated receptor gamma and the application in screening modulators of the receptor from herbal medicine. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1190: 123098. PMID 35026651 DOI: 10.1016/j.jchromb.2022.123098   
2022 Duarte DA, Parreiras-E-Silva LT, Oliveira EB, Bouvier M, Costa-Neto CM. Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time. Hypertension (Dallas, Tex. : 1979). 79: 115-125. PMID 34739768 DOI: 10.1161/HYPERTENSIONAHA.121.17977   
2022 Dijkstra FM, Zuiker RGJA, Siebenga PS, Leigh-Pemberton RA, Sun L, Manthis JD, de Kam ML, Lin R, von Moltke LL, Rezendes D, van Gerven JMA. Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers. British Journal of Clinical Pharmacology. PMID 35014069 DOI: 10.1111/bcp.15229   
2022 Morstein J, Romano G, Hetzler B, Plante A, Haake C, Levitz J, Trauner D. Photoswitchable Serotonins for Optical Control of the 5-HT2A Receptor. Angewandte Chemie (International Ed. in English). PMID 34989082 DOI: 10.1002/anie.202117094   
2022 Taban Q, Mumtaz PT, Masoodi KZ, Haq E, Ahmad SM. Scavenger receptors in host defense: from functional aspects to mode of action. Cell Communication and Signaling : Ccs. 20: 2. PMID 34980167 DOI: 10.1186/s12964-021-00812-0   
2022 Zhang W, Zhao S, Lu L, Fan Z, Ye S. Activation of neurotrophin signalling with light‑inducible receptor tyrosine kinases. Molecular Medicine Reports. 25. PMID 35014690 DOI: 10.3892/mmr.2022.12586   
2022 Acher FC, Cabayé A, Eshak F, Goupil-Lamy A, Pin JP. Metabotropic glutamate receptor orthosteric ligands and their binding sites. Neuropharmacology. 204: 108886. PMID 34813860 DOI: 10.1016/j.neuropharm.2021.108886   
2022 Zimmermann A, Vu O, Brüser A, Sliwoski G, Marnett LJ, Meiler J, Schöneberg T. Mapping the binding sites of UDP and prostaglandin E2 glyceryl ester in the nucleotide receptor P2Y6. Chemmedchem. PMID 35034430 DOI: 10.1002/cmdc.202100683   
2022 Li W, Wan L, Duan S, Xu J. Bibliometric analysis of toll-like receptor agonists associated with cancer therapy. Medicine. 101: e28520. PMID 35029915 DOI: 10.1097/MD.0000000000028520   
2022 Takeshita Y, Kita Y, Tanaka T, Goto H, Nakano Y, Teramura C, Enyama Y, Takamura T, . Insulin-GLP-1 receptor agonist relay and GLP-1 receptor agonist first regimens in individuals with type 2 diabetes: a randomized, open-label trial study. Journal of Diabetes Investigation. PMID 35034428 DOI: 10.1111/jdi.13749   
2022 Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, Ashina M, van den Maagdenberg AMJM, Dodick DW. Migraine. Nature Reviews. Disease Primers. 8: 2. PMID 35027572 DOI: 10.1038/s41572-021-00328-4   
2022 Conroy JN, Coulson EJ. High-affinity TrkA and p75 neurotrophin receptor complexes: a twisted affair. The Journal of Biological Chemistry. 101568. PMID 35051416 DOI: 10.1016/j.jbc.2022.101568